Table of Contents
Dataset Papers in Science
Volume 2014, Article ID 250694, 10 pages
http://dx.doi.org/10.1155/2014/250694
Dataset Paper

The In Vitro Susceptibility of Biofilm Forming Medical Device Related Pathogens to Conventional Antibiotics

Biomaterials, Biofilm and Infection Control Research Group, School of Pharmacy, Queens University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK

Received 31 October 2013; Accepted 10 February 2014; Published 1 June 2014

Academic Editors: T. Coenye and L. M. Teixeira

Copyright © 2014 Garry Laverty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Guggenbichler, O. Assadian, M. Boeswald, and A. Kramer, “Incidence and clinical implication of nosocomial infections associated with implantable biomaterials—catheters, ventilator-associated pneumonia, urinary tract infections,” GMS Krankenhhyg Interdiszip, vol. 6, no. 1, article 18, 2011. View at Publisher · View at Google Scholar
  2. K. Lewis, “Multidrug tolerance of biofilms and persister cells,” Current Topics in Microbiology and Immunology, vol. 322, pp. 107–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. R. Allison, M. P. Brynildsen, and J. J. Collins, “Heterogeneous bacterial persisters and engineering approaches to eliminate them,” Current Opinion in Microbiology, vol. 14, no. 5, pp. 593–598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Hulscher, R. P. Grol, and J. W. van der Meer, “Antibiotic prescribing in hospitals: a social and behavioural scientific approach,” The Lancet Infectious Diseases, vol. 10, no. 3, pp. 167–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Mermel, M. Allon, E. Bouza et al., “Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 49, no. 1, pp. 1–45, 2009. View at Publisher · View at Google Scholar
  6. M. B. Bestul and H. L. VandenBussche, “Antibiotic lock technique: review of the literature,” Pharmacotherapy, vol. 25, no. 2, pp. 211–227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Capdevila, A. Segarra, A. M. Planes et al., “Successful treatment of haemodialysis catheter-related sepsis without catheter removal,” Nephrology Dialysis Transplantation, vol. 8, no. 3, pp. 231–234, 1993. View at Google Scholar · View at Scopus
  8. J.-L. Benoit, G. Carandang, M. Sitrin, and P. M. Arnow, “Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home,” Clinical Infectious Diseases, vol. 21, no. 5, pp. 1286–1288, 1995. View at Google Scholar · View at Scopus
  9. H. Bagnall-Reeb, “Evidence for the use of the antibiotic lock technique,” Journal of Infusion Nursing, vol. 27, no. 2, pp. 118–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Rotstein, L. Brock, and R. S. Roberts, “The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients,” Infection Control and Hospital Epidemiology, vol. 16, no. 8, pp. 451–458, 1995. View at Google Scholar · View at Scopus
  11. P. M. Arnow, E. M. Quimosing, and M. Beach, “Consequences of intravascular catheter sepsis,” Clinical Infectious Diseases, vol. 16, no. 6, pp. 778–784, 1993. View at Google Scholar · View at Scopus
  12. J. Rodriguez-Bano, “Selection of empiric therapy in patients with catheter-related infections,” Clinical Microbiology and Infection, vol. 8, no. 5, pp. 275–281, 2002. View at Publisher · View at Google Scholar
  13. W. Graninger, O. Assadian, H. Lagler, and M. Ramharter, “The role of glycopeptides in the treatment of intravascular catheter-related infections,” Clinical Microbiology and Infection, vol. 8, no. 5, pp. 310–315, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. P. Ruiz-Valverde, J. R. Barberà, A. Segarra, J. A. Capdevila, A. Evangelista, and L. Piera, “Successful treatment of catheter-related sepsis and extraluminal catheter thrombosis with vancomycin and fraxiparin without catheter removal,” Nephron, vol. 75, no. 3, pp. 354–355, 1997. View at Google Scholar · View at Scopus
  15. J. M. Boyce, L. A. Mermel, M. J. Zervos et al., “Controlling vancomycin-resistant enterococci,” Infection Control and Hospital Epidemiology, vol. 16, no. 11, pp. 634–637, 1995. View at Google Scholar · View at Scopus
  16. L. A. Mermel, B. M. Farr, R. J. Sherertz et al., “Guidelines for the management of intravascular catheter-related infections,” Clinical Infectious Diseases, vol. 32, no. 9, pp. 1249–1272, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Peters and K. Becker, “Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus,” Drugs, vol. 52, supplement 2, pp. 50–54, 1996. View at Google Scholar · View at Scopus
  18. H. N. Bentur, A. M. Dalzell, and F. A. I. Riordan, “Central venous catheter infection with Bacillus pumilus in an immunocompetent child: a case report,” Annals of Clinical Microbiology and Antimicrobials, vol. 6, article 12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. H. Crabtree and N. A. Garcia, “Corynebacterium striatum peritoneal dialysis catheter exit site infection,” Clinical Nephrology, vol. 60, no. 4, pp. 270–274, 2003. View at Google Scholar · View at Scopus
  20. D. S. Swanson, “Central venous catheter-related infections due to nontuberculous Mycobacterium species,” Pediatric Infectious Disease Journal, vol. 17, no. 12, pp. 1163–1164, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. P. Guay, “Nontuberculous mycobacterial infections,” Annals of Pharmacotherapy, vol. 30, no. 7-8, pp. 819–830, 1996. View at Google Scholar · View at Scopus
  22. M. V. Gill, H. Ly, M. Mueenuddin, P. E. Schoch, and B. A. Cunha, “Intravenous line infection due to Ochrobactrum anthropi (CDC group Vd) in a normal host,” Heart & Lung, vol. 26, no. 4, pp. 335–336, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. Ashby, J. E. Neale, S. J. Knott, and I. A. Critchley, “Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli,” Journal of Antimicrobial Chemotherapy, vol. 33, no. 3, pp. 443–452, 1994. View at Google Scholar · View at Scopus
  24. H. Ishida, Y. Ishida, Y. Kurosaka, T. Otani, K. Sato, and H. Kobayashi, “In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 7, pp. 1641–1645, 1998. View at Google Scholar · View at Scopus
  25. E. Bouza, A. Burillo, and P. Muñoz, “Catheter-related infections: diagnosis and intravascular treatment,” Clinical Microbiology and Infection, vol. 8, no. 5, pp. 265–274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Stepanović, D. Vuković, I. Dakić, B. Savić, and M. Švabić-Vlahović, “A modified microtiter-plate test for quantification of staphylococcal biofilm formation,” Journal of Microbiological Methods, vol. 40, no. 2, pp. 175–179, 2000. View at Publisher · View at Google Scholar
  27. G. Laverty, M. McLaughlin, C. Shaw, S. P. Gorman, and B. F. Gilmore, “Antimicrobial activity of short, synthetic cationic lipopeptides,” Chemical Biology & Drug Design, vol. 75, no. 6, pp. 563–569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Ceri, M. E. Olson, C. Stremick, R. R. Read, D. Morck, and A. Buret, “The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms,” Journal of Clinical Microbiology, vol. 37, no. 6, pp. 1771–1776, 1999. View at Google Scholar · View at Scopus
  29. C. W. Stratton, C. Liu, H. B. Ratner, and L. S. Weeks, “Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies,” Antimicrobial Agents and Chemotherapy, vol. 31, no. 7, pp. 1014–1016, 1987. View at Google Scholar · View at Scopus
  30. C. W. Stratton, C. Liu, and L. S. Weeks, “Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies,” Antimicrobial Agents and Chemotherapy, vol. 31, no. 8, pp. 1210–1215, 1987. View at Google Scholar · View at Scopus
  31. G. A. Pankuch, M. R. Jacobs, and P. C. Appelbaum, “Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 9, pp. 2065–2072, 1994. View at Google Scholar · View at Scopus
  32. K. Smith, A. Perez, G. Ramage, C. G. Gemmell, and S. Lang, “Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin,” International Journal of Antimicrobial Agents, vol. 33, no. 4, pp. 374–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. A. Miles, S. S. Misra, and J. O. Irwin, “The estimation of the bactericidal power of the blood,” Journal of Hygiene, vol. 38, no. 6, pp. 732–749, 1938. View at Publisher · View at Google Scholar
  34. P. Wu and D. W. Grainger, “Drug/device combinations for local drug therapies and infection prophylaxis,” Biomaterials, vol. 27, no. 11, pp. 2450–2467, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Balaban, A. Giacometti, O. Cirioni et al., “Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis,” Journal of Infectious Diseases, vol. 187, no. 4, pp. 625–630, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. N. P. O'Grady, M. Alexander, E. P. Dellinger et al., “Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention,” MMWR. Recommendations and Reports, vol. 51, no. 10, pp. 1–29, 2002. View at Google Scholar · View at Scopus
  37. C. Perry and C. Hall, “Antibiotic resistance: how it arises, the current position and strategies for the future,” Nursing Times, vol. 105, no. 36, pp. 20–23, 2009. View at Google Scholar · View at Scopus
  38. G. Laverty, S. P. Gorman, and B. F. Gilmore, “The potential of antimicrobial peptides as biocides,” International Journal of Molecular Sciences, vol. 12, no. 10, pp. 6566–6596, 2011. View at Publisher · View at Google Scholar · View at Scopus